The first report of Omakase’s new series of publications called “Omakase Lab Reports” is available for download
The report titled "European Commission Approved Orphan Drugs (ODs) 2012-2016: An [...]
Omakase attended the II National Symposium on Biosimilars organised by Biosim
Omakase attended the II National Symposium on Biosimilars, held in Madrid on the [...]
2017 Budgetary Provision Proposal for Orphan Drugs in Spain
The Spanish Socialist Party representatives have recently presented a formal req [...]
2017 BUDGETARY PROVISION PROPOSAL FOR ORPHAN DRUGS IN SPAIN
The Spanish Socialist Party representatives have recently presented a formal req [...]
“THE BEST IDEAS OF 2016” AWARD IN THE CATEGORY OF RESEARCH AND PHARMACOLOGY
"The Best Ideas of 2016" Award in the category of Research and Pharmacology. Oma [...]
“The Best Ideas of 2016” Award in the category of Research and Pharmacology
Omakase Consulting, leading company in Multicriteria Decision Analysis (MCDA) wa [...]
OMAKASE CONSULTING AWARDED “THE BEST IDEAS OF 2016”
The idea of Multicriteria Decision Analysis (MCDA) of Omakase Consulting has bee [...]
Omakase Consulting Awarded “The Best Ideas of 2016”
The idea of Multicriteria Decision Analysis (MCDA) of Omakase Consulting has bee [...]
COLLABORATION AGREEMENT FOR PATIENTS IN THE CROSS BORDERS BETWEEN VALENCIA AND ARAGON
Collaboration agreement between the Spanish Valencian and Aragon Autonomous regi [...]
Collaboration Agreement for Patients in the Cross Borders between Valencia and Aragon
Collaboration agreement between the Spanish Valencian and Aragon Autonomous r [...]